antioxidants Review Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation Fumiaki Ito 1,*, Yoko Sono 2 and Tomoyuki Ito 3,4 1 The Institute of Prophylactic Pharmacology, Shinagawa, Tokyo 140-0001, Japan 2 R&D Department, Sunstar Inc., Takatsuki, Osaka 569-1195, Japan;
[email protected] 3 Physical Medicine and Rehabilitation, Tanabe Memorial Hospital, Kyotanabe-City, Kyoto 610-0331, Japan;
[email protected] 4 Department of Rehabilitation Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan * Correspondence: setsunanfi@zmail.plala.or.jp; Tel.: +81-743-79-3910 Received: 15 March 2019; Accepted: 20 March 2019; Published: 25 March 2019 Abstract: Endothelial dysfunction is one of the initial steps in the pathogenesis of atherosclerosis and development of cardiovascular disease in patients with diabetes mellitus. Several risk factors are associated with endothelial dysfunction and atherosclerosis, such as hypertension, dyslipidaemia, inflammation, oxidative stress, and advanced glycation-end products. Among these risk factors, oxidative stress is the largest contributor to the formation of atherosclerotic plaques. Measurement of reactive oxygen species (ROS) is still difficult, and assays for the measurement of ROS have failed to show a consistent correlation between pathological states and oxidative stress. To solve this problem, this review summarizes the current knowledge on biomarkers of oxidative stress, especially lipid peroxidation, and discusses the roles of oxidative stress, as measured by indices of lipid peroxidation, in diabetes mellitus, atherosclerosis, and chronic inflammation. Keywords: oxidative stress; oxidative stress biomarkers; lipid peroxidation; 8-isoprostaglandin F2α; malondialdehyde; Fe-ROMs test; diabetes mellitus; endothelial dysfunction; atherosclerosis; cardiovascular disease; chronic inflammation; oxidized high-density lipoprotein 1.